A Long-Term Safety Follow-up Registry for Patients Who Received Treatment with Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

Project: Research project

Project Details

StatusActive
Effective start/end date12/29/25 → 12/28/40

Funding

  • Abeona Therapeutics Inc ( Award # ): $15,000.00